一对手性Salen型席夫碱对映体的合成、结构与生物活性

采取分步反应法以1R,2R-环己二胺(或1S,2S-环己二胺)与2-羟基萘甲醛和水杨酸苯酯反应,合成了一对手性Salen型席夫碱对映体:1R-(2-羟基苯甲酰亚胺)-2R-(2-羟基萘甲亚胺)环己烷(1a)和1S-(2-羟基苯甲酰亚胺)-2S-(2-羟基萘甲亚胺)环己烷(1b),对其进行了单晶结构、圆二色光谱、元素分析、红外光谱表征及生物活性实验。单晶结构与圆二色光谱分析表明1a和1b互为对映体;生物活性实验显示1a具有一定的抑菌活性。     

α-亚胺酮的不对称转移氢化合成(R)-沙丁胺醇

用手性(S,S)-Ru-TsDPEN催化剂不对称转移氢化α-亚胺酮化合物5-[(1,1-二甲基乙基)亚胺基]乙酰基-2-羟基苯甲酸甲酯(2)得光学纯β-氨基芳基乙醇类化合物(R)-5-[2-[(1,1-二甲基乙基)氨基]-1-羟乙基]-2-羟基苯甲酸甲酯(3), 再经一步还原反应即得(R)-(－)-沙丁胺醇. 对反应关键一步α-亚胺酮的不对称转移氢化反应条件进行了研究.     

手性硼酸酯介入的不对称合成3† (R)-或(S)-1,1'-联-2-萘酚硼酸-(S)-脯氨酸酐促进的前手性亚胺的不对称硼烷还原

手性螺硼酸酯(R)-或(S)-1,1'-联-2-萘酚硼酸-(S)-脯氨酸酐[(R,S)-1或(S,S)-1]对前手性亚胺硼烷还原的不对称催化活性被观察到. 在(R,S)-1或 (S,S)-1存在下, 由前手性二烷基酮或烷基苯酮与苯胺缩合生成的前手性亚胺在THF中被硼烷还原, 高产率地给出手性仲胺, 其对映体纯度高达74% ee. 其中, 三种手性仲胺[N-(2-戊基)苯胺, N-(3-甲基-2-丁基)苯胺和N-(4-甲基-2-戊基)苯胺]系首次合成.     

手性3,5-二甲基-2-芳基-2-吗啉醇盐酸盐的合成及其晶体结构

以(S)-2-氨基丙醇为手性源与α-溴-3-氯苯丙酮反应, (R)-2-氨基丙醇为手性源与6-甲氧基-2-(2-溴丙酰基)萘反应, 分别合成了手性纯化合物(2R,3R,5S)-3,5-二甲基-2-(3-氯苯基)-2-吗啉醇盐酸盐(4a)和(2S,3S,5R)-3,5-二甲基-2-(6-甲氧基-2-萘基)-2-吗啉醇盐酸盐(4b), 利用X射线单晶衍射仪测定了两化合物的晶体结构和两化合物的空间结构, 并初步分析两化合物空间结构, 化合物4a晶体属正交晶系, 空间群为P2₁2₁2, 晶胞参数为: a＝0.8718(2) nm, b＝0.7883(2) nm, c＝2.0247(6) nm, Z＝4, V＝1.3915(7) nm³, D_c＝1.328 g/cm³, F(000)＝584, R₁＝0.0399, wR₂＝0.0797, S＝1.042. 化合物4b晶体属正交晶系, 空间群为P2₁2₁2₁, 晶胞参数为: a＝0.71035 (9) nm, b＝0.77703(10) nm, c＝2.9820(4) nm, Z＝4, V＝1.6318(4) nm³, D_c＝1.318 g/cm³, F(000)＝688, R₁＝0.0520, wR₂＝0.1108, S＝0.994.     

光学活性化合物多羟基庚酸乙酯的合成

以不对称环氧化和双羟化反应为构筑手性碳的关键步骤, 首次合成了(＋)-(2R,3S,4S,5S)-6-甲基-4,5-环氧-2,3-二羟基-庚酸乙酯(5)和(－)-(2R,3S,4R,5S)-6-甲基-2,3,4,5-四羟基-庚酸乙酯(11). 找到一条适宜于该类化合物合成的简便有效且立体选择性好的合成路线. 初步生物活性测试表明, 化合物5, 11对HL60细胞具有抑制活性.     

乳酸类合成子构建的四连接螺旋手性配位聚合物的合成、结构和光催化性质

通过乳酸衍生物和3-溴-4-羟基苯甲酸的组合得到对映体3-溴-4-(((1R)-1-羧基乙基)氧基)苯甲酸(R-H₂bba)和3-溴-4-(((1S)-1-羧基乙基)氧基)苯甲酸(S-H₂bba)。以其为手性合成子在水热条件下分别与1,3-二(吡啶-4-基)丙烷(1,3-dpp)和Ni²⁺反应,构建了对映手性配位聚合物{[Ni(R-bba)(1,3-dpp)(H₂O)_0.5]·1.5H₂O}_n (HU12-R)和{[Ni(S-bba)(1,3-dpp)(H₂O)_0.5]·1.5H₂O}_n (HU12-S)。结构分析揭示HU12-R和HU12-S是具有dia网络特征的三维螺旋骨架。在骨架中,阴离子配体R-bba^2-和S-bba^2-分别与Ni²⁺中心连接在一起围绕2₁螺旋轴得到一对小的对映螺旋链,而1,3-dpp与Ni²⁺中心则围绕4₁螺旋轴构建出另外一对大的对映螺旋链。电化学测试显示HU12-R属n型半导体,具有低阻抗性质,对紫外可见光有很强的吸收能力。进一步光催化实验证实在紫外光照射下所得配合物对染料降解有明显催化效果。     

N,N'-二茂铁甲基-(1S,2S)-1,2-二苯基乙二胺的合成及其在烯烃的不对称双羟基化反应中的应用

(1S,2S)-1,2-二苯基乙二胺和甲酰基二茂铁经缩合和还原两步反应, 以90%的产率合成了N,N'-二茂铁甲基-(1S,2S)-1,2-二苯基乙二胺, 并以其为配体催化烯烃的不对称双羟基化反应, 获得了较高的对映选择性(71%～86% ee).     

两个手性Salen型过渡金属配合物的合成、波谱与结构

本文报道了2个手性Salen型过渡金属配合物[(N,N′-bis(3-t-butyl-5-methylsalicylidene)-1S,2S-cyclohexanediamine-N,N′,O,O′) nickel(Ⅱ)] (1)和[(N,N′-bis(3-t-butyl-5-methylsalicylidene)-1S,2S-cyclohexanediamine-N,N′,O,O′) copper(Ⅱ)] (2)的合成、波谱与结构表征。它们由(1S,2S)-环己烷-1,2-二胺和3-叔丁基-5-甲基-2-羟基苯甲醛发生席夫碱缩合反应制得的配体分别与Cu(Ⅱ)和Ni(Ⅱ)盐反应而得到。产品经过红外光谱、元素分析、电喷雾质谱、紫外和圆二色光谱等方法表征,并测定其晶体结构。结果表明配合物1和2中的中心金属离子Cu(Ⅱ)和Ni(Ⅱ)均为四配位平面正方形配位构型,而且在其晶体堆积中观察到一种通过芳环之间弱π-π相互作用形成的二聚结构。     

改性Ultrastable-Y分子筛固定化对非水相中脂肪酶拆分(R,S)-2-辛醇的影响

采用改性Ultrastable-Y分子筛固定Penicillium expansum PED-03 脂肪酶(PEL), 利用固定化PEL在非水相中对(R,S)-2-辛醇进行手性拆分, 考察了改性Ultrastable-Y分子筛固定化处理对PEL催化性能的影响. 结果表明, 与游离PEL及经其它载体固定化的PEL相比, 改性Ultrastable-Y分子筛固定的PEL所催化的拆分反应的转化率(c)和对映体过量值(ee)以及对映体选择性(E)均得到了较大提高. 经固定化处理后, PEL的最适反应温度明显升高, 适宜反应温度范围变宽, 其稳定性也得到了明显改善, 而适宜反应pH值则具有“记忆”性. 在间歇式反应器中利用Ultrastable-Y分子筛固定化PEL对(R,S)-2-辛醇进行手性拆分, 50 ℃反应24 h转化率(c)可达理论值的97.68%, 对映体过量值(ee)可达98.75%. 连续8批拆分反应的结果表明: 改性Ultrastable-Y分子筛固定化脂肪酶催化效率高、立体选择性强(平均E 值＞460), 且催化性能稳定, 显示了该固定化酶在(R,S)-2-辛醇的手性拆分方面具有良好的应用前景.     

刺乌头碱氢溴酸盐的合成及晶体结构

报道了以双溴代烷烃和刺乌头碱合成刺乌头碱氢溴酸盐的方法. 用元素分析、红外光谱、高分辨质谱和核磁共振进行了表征. 并用X射线单晶衍射确定了标题化合物的绝对构型. 晶体结构表明, 该化合物通过分子间氢键形成了网状类似超分子结构. 晶体属于单斜晶系, P2₁空间群, 晶胞参数: a＝1.0619(2) nm, b＝1.2196(3) nm, c＝1.2282(2) nm, β＝90.87(1)°, V＝1.59037(54) nm³, Z＝2, D_m＝1.428 g/cm^－3, F(000)＝720.0, µ＝1.349 mm^－1. 环 A, B, C, D, E和F分别呈船式、椅式、信封式、船式、船式和信封式. 其绝对构型被确定为1S,4S,5S,7S,8S,9S,10S,11S,13R,14S,16S,17R.     

Synthesis of chiral 3-substituted-3-aminomethyl-pyrrolidines and related compounds

The preparation of a series of chiral 3-methyl-3-substituted-pyrrolidines/pyrrolidinones starting from (R)-4-(methoxycarbonyl)-1-(1R-phenethyl)-2-pyrrolidinone ( 1 ) is described. The chiral α-methylbenzyl functionality serves not only as a nitrogen protecting group for the pyrrolidine nitrogen, but also as a chiral auxillary. The synthesis of the 4-position enantiomers was accomplished by converting the ester of 1 to the ketone, protecting the ketone as the benzyloxime and separation by chromatography. These key intermediates were converted to the (R) and (S)-3-methyl-3-aminomethylpyrrolidines by removal of the benzyl group followed by oxidation. The 3-methyl-3-(1-aminoethyl)pyrrolidines were obtained via a two step reduction of the corresponding oximes. The stereochemical assignments were determined by X-ray crystallography.     

Chiral Recognition of Propranolol with <Emphasis Type="Bold">β</Emphasis>-Cyclodextrin in the Presence of 1- and 2-Butanol

The purpose of this work is to investigate the chiral recognition characteristics of β-cyclodextrin with two propranolol enantiomers in the presence of organic additives. Steady-state fluorescence measurements of propranolol β-cyclodextrin (β-CD) complexes were performed for solutions containing either 1- or 2-butanol. For each 2-butanol isomer solution, the interactions were assessed by comparing the changes in the fluorescence of (R)-(+)- propranolol versus (S)-(-)-propranolol as a function of CD concentration. A similar comparison study was done for the propranolol enantiomers in the presence of 1-butanol. The intensity changes for propranolol are relatively small upon addition of β-CD in the presence of the butanol alcohol. However, the present work shows that the interaction of (R)-(+)-propranolol with β-CD is influenced by the chirality of 2-butanol in contrast to (S)-(-)-propranolol.This revised version was published online in July 2005 with a corrected issue number.     

Synthesis of enantiomers of 2′-aminomethyl-5-benzylacyclouridine (AM-BAU) and 2′-aminomethyl-5-benzyloxybenzylacyclouridine (AM-BBAU). Potent inhibitors of uridine phosphorylase

Racemic 2′-aminomethyl-5-benzyl-acyclouridine (AM-BAU, 5 ) and 2′-aminomethyl-5-benzyloxybenzyla-cyclouridine (AM-BBAU, 6 ) have been found to be very active inhibitors of uridine phosphorylase [1]. Their enantiomers were synthesized from chiral 2,2-dimethyl-1,3-dioxolane-4-methanol ( 7a,b ). S-(—)-AM-BAU ( 5a ) and S-(—)-AM-BBAU ( 6a ) were prepared from the R-(—) isomer 7a , and R(+)-AM-BAU ( 5b ) and R-(+)-AM-BBAU (6b) from the S-(+) isomer 7b . A different route from the S-(+) isomer 7b to S-(—)-AM-BBAU ( 6a ) was also determined to be feasible.     

Resolution of P-Sterogenic 1-Phenylphosphin-2-en-4-one 1-Oxide into Two Enantiomers by (R,R)-TADDOL and Conformational Diversity of the Phosphinenone Ring and TADDOL in the Crystal State

The resolution of racemic 1-phenylphosphin-2-en-4-one 1-oxide (2), was achieved through the fractional crystallization of its diastereomeric complexes with (4R,5R)-(−)-2,2-dimethyl -α,α,α′,α′-tetraphenyl-dioxolan-4,5-dimethanol (R,R-TADDOL) followed by the liberation of the individual enantiomers of 2 by flash chromatography on silica gel columns. The resolution process furnished the two enantiomers of 2 of 99.1 and 99.9% e.e. at isolated yields of 62 and 59% (counted for the single enantiomer), respectively. The absolute configurations of the two enantiomers were established by means of X-ray crystallography of their diastereomerically pure complexes, i.e., (R)-2•R,R)-TADDOL and (S)-2•(R,R)-TADDOL. The structural analysis revealed that in the (R)-2•(R,R)-TADDOL complex, the P-phenyl substituent occupied a pseudoequatorial position, whereas in (S)-2•(R,R)-TADDOL, it appeared in both the pseudoequatorial and the pseudoaxial positions in four symmetrically independent molecules. Concurrent conformational changes of the TADDOL molecules were best described by the observed changes of a pseudo-torsional CO...OC angle that could be considered as a possible measure of TADDOL conformation in its receptor–ligand complexes. The structural analysis of the (R,R)-TADDOL molecule revealed that efficiency of this compound for use as an effective resolving factor comes from its ability to flexibly fit its structure to both enantiomers of a ligand molecule, producing a rare case of resolution for both pure enantiomers with one chiral separating agent. The resolved (R)-2 was used to assign the absolute configuration of a recently described (−)-1-phenylphosphin-2-en-4-one 1-sulfide by chemical correlation. In addition, an attempted stereoretentive reduction of (R)-2 by PhSiH₃ at 60 °C revealed an unexpectedly low barrier for P-inversion in 1-phenylphosphin-2-en-4-one.     

The crystal structures of chiral (<Emphasis Type="Italic">R</Emphasis>/<Emphasis Type="Italic">S</Emphasis>) (C<Subscript>8</Subscript>H<Subscript>11</Subscript>N)<Subscript>2</Subscript>·CuCl<Subscript>2</Subscript>

Two opposite configuration (R/S) of chiral complexes (C₈H₁₁N)₂·CuCl₂ were obtained from the reaction of chiral d(+)/l(−)-α-ethylphenyl amine with copper chloride (II) in dry ethanol. The crystal structures of 1a and 1b were characterized by IR, elemental analysis and X-ray crystallography.     

Synthesis,crystal structure,and absolute configuration of the enantiomers of chiral drug xibenolol hydrochloride

Based on the features of its crystallization, racemic 3-(2,3-dimethylphenoxy)propane-1,2-diol 2, the synthetic precursor of the chiral drug xibenolol 1, was resolved into pure enantiomers by the direct method of entrainment. The enantiomers of diol 2 through a Mitsunobu reaction were converted into the nonracemic 1,2-epoxy-3-(2,3-dimethylphenoxy)propanes (S)- and (R)-3, and then into the xibenolol enantiomers. Single crystals of (+)- and (?)-1·HCl were studied by X-ray diffraction. On the basis of the Flack parameter, the absolute (R)- and (S)-configurations were assigned to these compounds and to the other intermediate chiral substances.     

Optisch aktive 3-Amino-2H-azirine als Bausteine für enantiomerenreine αα-disubstituierte α-Aminosäuren: Synthese von Isovalin-Synthonen und Einbau in ein Trichotoxin-A-50-Segment

Optically Active 3-Amino-2H-azirines as Synthons for Enantiomerically Pure αα-Disubstiuted α-Amino Acids: Syntheses of Isovaline Synthons and a Segment of Trichotoxin A-50 The synthesis of a novel 3-amino-2-methyl-2-[2-(phenylsulfonyl)ethyl]-2H-azirine derivative 12 with a chiral substituent at the amino group is described. Chromatographic separation of the diastereoisomer mixture gave pure diastereoisomers which, after an electrochemical cleavage of the phenylsulfonyl group, yielded the (S)- and (R)-isovalin (Iva) synthons 13a and 13b , respectively. The absolute configuration of the precursor molecule 12b was established by X-ray crystallography. The Iva synthons were successfully used in the synthesis of the C-terminal pentapeptide Z-Leu-Aib-(R)-Iva-Gln-Valol of the peptaibole Trichotoxin A-50 and its epimer.     

Synthesis and configuration of the cyclin-dependent kinase inhibitor roscovitine and its enantiomer

The cyclin-dependent kinase inhibitor (R)-2-(6-benzylamino-9-isopropyl-9H-purin-2-ylamino)butan-1-ol (roscovitine, 1a), as well as its (S)-enantiomer 1b, were synthesised. The chemical structure and absolute configuration of both enantiomers was confirmed by X-ray crystallography. Furthermore, high enantiomeric excess (>98%) was demonstrated by chiral chromatography of 1a and 1b, as well as NMR analysis of the diastereomeric Mosher's ester derivatives 2a and 2b.     

Estimation of apparent binding constant of complexes of selected acyclic nucleoside phosphonates with β‐cyclodextrin by affinity capillary electrophoresis

Affinity capillary electrophoresis (ACE) has been applied to estimation of apparent binding constant of complexes of (R,S)‐enantiomers of selected acyclic nucleoside phosphonates (ANPs) with chiral selector β‐cyclodextrin (βCD) in aqueous alkaline medium. The noncovalent interactions of five pairs of (R,S)‐enantiomers of ANPs‐based antiviral drugs and their derivatives with βCD were investigated in the background electrolyte (BGE) composed of 35 or 50 mM sodium tetraborate, pH 10.0, and containing variable concentration (0–25 mM) of βCD. The apparent binding constants of the complexes of (R,S)‐enantiomers of ANPs with βCD were estimated from the dependence of effective electrophoretic mobilities of (R,S)‐enantiomers of ANPs (measured simultaneously by ACE at constant reference temperature 25°C inside the capillary) on the concentration of βCD in the BGE using different nonlinear and linear calculation methodologies. Nonlinear regression analysis provided more precise and accurate values of the binding constants and a higher correlation coefficient as compared to the regression analysis of the three linearized plots of the effective mobility dependence on βCD concentration in the BGE. The complexes of (R,S)‐enantiomers of ANPs with βCD have been found to be relatively weak – their apparent binding constants determined by the nonlinear regression analysis were in the range 13.3–46.4 L/mol whereas the values from the linearized plots spanned the interval 12.3–55.2 L/mol.